The immuno-AVI-PDX, am innovative patient-derived xenograft model for preclinical immuno-oncology studies

被引：0
|
作者：
Lacourrege, Marjorie
Costechareyre, Clelia
Jarrosson, Loraine
Teinturier, Romain
Berget, Frederic
Delloye-Bourgeois, Celine
Castellani, Valerie
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1459
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preclinical models of patient derived xenografts (PDX) for immuno-oncology research
    Stecklum, M.
    Wulf-Goldenberg, A.
    Brzezicha, B.
    Fichtner, I.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S59 - S60
  • [2] Patient-derived explant cultures (PDECs) as a model system for immuno-oncology studies
    Turpin, Rita
    Munne, Pauliina
    Suleymanova, Ilida
    Mustjoki, Satu
    Pouwels, Jeroen
    Klefstrom, Juha
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Patient-Derived Explant Cultures (PDECs) as a model system for immuno-oncology studies
    Turpin, R.
    Munne, P. M.
    Suleymanova, I.
    Mustjoki, S.
    Pouwels, J.
    Klefstrom, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] New patient-derived head and neck cancer xenograft (PDX) panel for drug development, immuno-oncology and translational research
    Brzezicha, Bernadette
    Conrad, Theresia
    Stecklum, Maria
    Becker, Michael
    Klinghammer, Konrad
    Hoffmann, Jens
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [5] Patient-derived xenograft (PDX) and corresponding cell line models from glioblastoma for drug development, immuno-oncology and translational research
    Alcaniz, Joshua
    Winkler, Lars
    Stecklum, Maria
    Wieland, Hagen
    Siegert, Antje
    Becker, Michael
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2023, 83 (07)
  • [6] New patient derived lymphoma xenograft (PDX) panel for drug development, immuno-oncology and translational research
    Brzezicha, B.
    Becker, M.
    Stecklum, M.
    Conrad, T.
    Janz, M.
    Bittner, A.
    Schmitt, C. A.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S41 - S41
  • [7] Development and validation of a patient derived xenograft based preclinical platform for immuno-oncology drug development
    Oswald, E.
    Grote, A.
    Bug, D.
    Loehr, A.
    Lenhardt, D.
    Niedermann, G.
    Merhof, D.
    Feuerhake, F.
    Schueler, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S108 - S108
  • [8] Development of autologous tumor: TIL coculture from patient-derived samples for in vitro preclinical immuno-oncology studies
    Hinata, Kaede
    Cuff, Patrice
    Liang, Wei
    Broudy, Thomas
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [9] Preclinical models for translational immuno-oncology research: Rare patient-derived xenografts on humanized mice
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Preclinical models for translational immuno-oncology research: patient-derived xenografts on humanized mice.
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Klinghammer, Konrad
    Joehrens, Korinna
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2021, 81 (13)
12345